<DOC>
	<DOCNO>NCT00487526</DOCNO>
	<brief_summary>Study effect Duodenal jejunal bypass human adult type 2 diabetes .</brief_summary>
	<brief_title>Duodenal Jejunal Bypass Type 2 Diabetes ( DJBD )</brief_title>
	<detailed_description>Adults non obese ( BMI less 34 ) undergo duodenal jejunal bypass . The Outcome measure : Blood Sugar , Insulin , HbA1c , CCK , Gastrin , GIP1and 2 , Ghrelin , Cholesterol , Triglycerides , FFA , C-Peptide .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Adults age 2065 Clinical diagnosis type 2 diabetes Non obese BMI le 34 . Oral agent insulin control T2DM . Inadequate control diabetes define HbA1c &gt; /7.5 Understanding mechanisms action treatment Children type 1 diabetes Obese BMI 34 Coagulopathy Liver cirrhosis Unable comply study requirement , followup give valid consent Currently pregnant Previous upper abdominal surgery Inabilty tolerate general anesthesia</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Bypass</keyword>
	<keyword>Duodenal jejunal</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>non-obese adult</keyword>
</DOC>